Cervical lymphadenopathy following botulinum toxin type A injection for masseter hypertrophy: Is it just a coincidence?

J Cosmet Dermatol. 2022 Oct;21(10):5264-5265. doi: 10.1111/jocd.14904. Epub 2022 Mar 14.

Authors

Mengying Leng¹, Haiguang Zhao¹

Affiliation

¹ Department of Plastic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.

PMID: 35263487
DOI: 10.1111/jocd.14904

No abstract available

Publication types

Letter

MeSH terms

Botulinum Toxins, Type A* / adverse effects
Humans
Hypertrophy / drug therapy
Injections, Intramuscular
Lymphadenopathy*
Masseter Muscle
Neuromuscular Agents* / adverse effects

Substances

Botulinum Toxins, Type A
Neuromuscular Agents

Supplementary concepts

Masticatory Muscles, Hypertrophy of